Ranibizumab in neovascular age-related macular degeneration: a 5-year follow-up

PURPOSE: Our aim was to evaluate an optical coherence tomography (OCT) and visual acuity (VA)-guided, variable-dosing regimen with intravitreal ranibizumab injection for treating patients with neovascular age-related macular degeneration (AMD) from 2007 to 2012. DESIGN: This was a retrospective clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Cvetkova, Nadezhda P, Hölldobler, Kristina, Prahs, Philipp, Radeck, Viola, Helbig, Horst, Märker, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907736/
https://www.ncbi.nlm.nih.gov/pubmed/27354758
http://dx.doi.org/10.2147/OPTH.S101050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907736/
https://www.ncbi.nlm.nih.gov/pubmed/27354758
http://dx.doi.org/10.2147/OPTH.S101050

Ejemplares similares